DOP2019000145A - IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING - Google Patents
IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARINGInfo
- Publication number
- DOP2019000145A DOP2019000145A DO2019000145A DO2019000145A DOP2019000145A DO P2019000145 A DOP2019000145 A DO P2019000145A DO 2019000145 A DO2019000145 A DO 2019000145A DO 2019000145 A DO2019000145 A DO 2019000145A DO P2019000145 A DOP2019000145 A DO P2019000145A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- lansoprazole
- symeticone
- preparing
- improved composition
- microgranules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Abstract
La presente invención se refiere a una composición farmacéutica de administración oral, que comprende la combinación a dosis fija de Simeticona en microgránulos de alta concentración y Lansoprazol o su enantiómero (Dexlansoprazol) en microgránulos de liberación entérica y el proceso para obtener los microgránulos de alta concentración de Simeticona.The present invention refers to a pharmaceutical composition for oral administration, which comprises the fixed dose combination of Simethicone in high concentration microgranules and Lansoprazole or its enantiomer (Dexlansoprazole) in enteric release microgranules and the process to obtain the high concentration microgranules of Simethicone.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2016016587A MX2016016587A (en) | 2016-12-14 | 2016-12-14 | Improved composition of lansoprazole and simeticone and method for preparing same. |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2019000145A true DOP2019000145A (en) | 2019-08-15 |
Family
ID=62558163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2019000145A DOP2019000145A (en) | 2016-12-14 | 2019-06-04 | IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING |
Country Status (9)
Country | Link |
---|---|
AR (1) | AR110183A1 (en) |
BR (1) | BR112019011966A2 (en) |
CL (1) | CL2019001462A1 (en) |
CO (1) | CO2019006693A2 (en) |
CR (1) | CR20190290A (en) |
DO (1) | DOP2019000145A (en) |
MX (1) | MX2016016587A (en) |
PE (1) | PE20191654A1 (en) |
WO (1) | WO2018109693A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5073384A (en) * | 1989-10-19 | 1991-12-17 | Valentine Enterprises, Inc. | Maltodextrin/defoaming composition combinate |
US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
US20050181052A1 (en) * | 2004-02-17 | 2005-08-18 | Patel Satishkumar A. | Lansoprazole microtablets |
WO2008056200A1 (en) * | 2006-11-10 | 2008-05-15 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of simethicone |
RU2602745C2 (en) * | 2011-12-14 | 2016-11-20 | Дисфар Интернэшнл Б.В. | Composition with simeticon |
-
2016
- 2016-12-14 MX MX2016016587A patent/MX2016016587A/en unknown
-
2017
- 2017-11-17 AR ARP170103219A patent/AR110183A1/en unknown
- 2017-12-13 PE PE2019001165A patent/PE20191654A1/en unknown
- 2017-12-13 WO PCT/IB2017/057904 patent/WO2018109693A1/en active Application Filing
- 2017-12-13 CR CR20190290A patent/CR20190290A/en unknown
- 2017-12-13 BR BR112019011966-3A patent/BR112019011966A2/en unknown
-
2019
- 2019-05-30 CL CL2019001462A patent/CL2019001462A1/en unknown
- 2019-06-04 DO DO2019000145A patent/DOP2019000145A/en unknown
- 2019-06-21 CO CONC2019/0006693A patent/CO2019006693A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR110183A1 (en) | 2019-03-06 |
CO2019006693A2 (en) | 2019-07-10 |
CL2019001462A1 (en) | 2019-08-23 |
WO2018109693A1 (en) | 2018-06-21 |
BR112019011966A2 (en) | 2019-11-05 |
MX2016016587A (en) | 2018-06-13 |
PE20191654A1 (en) | 2019-11-07 |
CR20190290A (en) | 2019-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124548T1 (en) | MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS | |
CY1122786T1 (en) | DOSAGE FORMS FOR Echinocandin Class Compounds | |
CY1122792T1 (en) | MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS | |
UY36339A (en) | MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION | |
CO2018003471A2 (en) | Indole mono- or disubstituted derivatives as inhibitors of dengue viral replication | |
CO2018009563A2 (en) | Indoline derivatives substituted as inhibitors of dengue viral replication | |
UY36518A (en) | DERIVATIVES OF INDOL MONO OR DISABLED AS INHIBITORS OF THE REPLICATION OF DENGUE VIRUSES | |
CL2017001026A1 (en) | Methods and compositions particularly for the treatment of attention deficit disorder. | |
CO2018009559A2 (en) | Indole derivatives substituted as inhibitors of dengue viral replication | |
PE20151301A1 (en) | PHARMACEUTICAL FORMULATIONS RESISTANT TO IMPROPER HANDLING | |
ECSP16084317A (en) | PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE | |
CL2017001483A1 (en) | Fixed ratio formulation of insulin glargine / lixisenatide | |
CL2016002560A1 (en) | Oral solid pharmaceutical dosage form comprising siponimod, a moisture protective agent and optionally a pharmaceutical excipient; Preparation procedure | |
MX2018012618A (en) | Oral pharmaceutical compositions of mesalazine. | |
CL2015003468A1 (en) | Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d. | |
PE20151607A1 (en) | ORGANIC COMPOUND FORMULATIONS | |
AR102778A1 (en) | PHARMACEUTICAL COMPOSITION, ITS PREPARATION AND ITS USES | |
AR108233A1 (en) | ORIC PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | |
DOP2019000145A (en) | IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING | |
ECSP19044926A (en) | IMPROVED COMPOSITION OF LANSOPRAZOLE AND SYMETICONE AND PROCESS FOR PREPARING | |
BR112018074655A2 (en) | fosnetupitant injectable formulation and method of manufacturing a formulation | |
ECSP16005208A (en) | STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS | |
UY37413A (en) | OPROZOMIB IMMEDIATE RELEASE FORMULATIONS | |
DOP2019000190A (en) | QUICK RELEASE COMPOSITION OF CINITAPRIDA AND SYMETICONE AND PROCESS TO PREPARE IT. | |
EA201691763A1 (en) | STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID |